CANF vs CLGN: Side-by-Side Comparison
Compare Can-Fite Biopharma Ltd (CANF) and CollPlant Biotechnologies Ltd New (CLGN) side by side: market cap USD 5.12M vs USD 4.91M. Financials, growth and model signals on Bullrun.
| Metric | CANF | CLGN |
|---|---|---|
| Company | Can-Fite Biopharma Ltd | CollPlant Biotechnologies Ltd New |
| Country / Exchange | Israel · NYSE MKT | Israel · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 5.12M | USD 4.91M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 405.00K | USD 2.37M |
| Revenue growth YoY | -39.9% | +360.4% |
| Net income | USD -9.83M | USD -11.49M |
| Gross margin | — | 64.8% |
| Diluted EPS | -5.97 | -0.94 |